Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network

28-Sep-2023 - Merck became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical stages of mRNA development, manufacturing, and commercialization, including products and testing. The company opened two new GMP-grade mRNA drug substance ...

CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA

23-Mar-2018 - CureVac AG announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance to CureVac on GMP-conforming pharmaceutical manufacturing methods for producing RNA, strengthening CureVac’s industry-leading position in GMP manufacturing of in vitro transcribed RNA. CureVac is the ...

Subsidiary Heidelberg Pharma contracts Celonic

Contract contains antibody cell line development and antibody production

28-Sep-2016 - WILEX AG, announced that its subsidiary Heidelberg Pharma, has signed an agreement with Celonic AG, Basel, Switzerland, a specialist in the development and manufacturing of biologics (CDMO). This agreement includes cell line development and the production of non-GMP and GMP (Good Manufacturing ...

vermicon AG is GMP certified

31-May-2012 - vermicon AG has now been certified in accordance with the GMP standard by the government of Upper Bavaria. It is now also an accredited pharmaceutical testing laboratory pursuant to § 67 para. 1 AMG (German Pharmaceuticals Act). “We want to share our years of experience across the various ...

Enzymicals AG and Herbrand PharmaChemicals GmbH cooperate for biotechnological production of pharmaceuticals and intermediates

19-Jan-2012 - "We are happy to establish processes from development via production to market entry together with Herbrand PharmaChemicals" states Dr. Menyes from Enzymicals AG while visiting the running production sites of Herbrand PharmaChemicals GmbH, where soon biocatalytic processes for the production of ...

PANATecs moves into new laboratories in Heilbronn in 2012

17-Nov-2011 - In Summer 2012, PANATecs moves its headquarters to Heilbronn, where the firm will have modern and purpose-built laboratories in the Wohlgelegen Research Park. The owner is Heilbronn City Development, which is planning a high technology park for young and innovative firms. PANATecs is the eighth ...

CHEMCON does it again: Flawless FDA Inspection

19-Jul-2011 - ChemCon´s facility in Freiburg, Germany has been cleared for the production of active pharmaceutical ingredients (APIs) by the US Food & Drug Administration FDA. According to the US regulator, the site is fully compliant with Current Good Manufacturing Practices (CGMP). FDA completed the renewal ...

Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year

08-Apr-2011 - Glycotope Biotechnology GmbH has initiated the setup of further clean room facilities as a first step in the expansion of its GMP-production capacities. By mid 2011, the company will thus be able to produce 4kg of recombinant antibodies per year and up to 11 kg upon completion of works towards ...